1) Motsitsi NS. Management of infected nonunion of long bones:the last decade (1996-2006). Injury 2008;39(2):155-60.
2) Struijs PA, Poolman RW, Bhandari M. Infected nonunion of the long bones. J Orthop Trauma 2007;21(7):507-11.
3) 渡部欣忍,佐々木源,宮本 亘・他.Masquelet法を用いた感染性偽関節の治療.臨整外2018;53(5):383-9.
4) Masquelet AC, Begue T. The concept of induced membrane for reconstruction of long bone defects. Orthop Clin North Am 2010;41(1):27-37.
5) Masquelet AC. Induced membrane technique:Pearls and pitfalls. J Orthop Trauma 2017;31;Suppl 5:S36-8.
6) Taylor BC, French BG, Fowler TT, et al. Induced membrane technique for reconstruction to manage bone loss. J Am Acad Orthop Surg 2012 Mar;20(3):142-50.
7) Giannoudis PV, Gudipati S, Harwood P, et al. Long bone non-unions treated with the diamond concept:a case series of 64 patients. Injury 2015;46 Suppl 8:S48-54.
8) Cuthbert RJ, Churchman SM, Tan HB, et al. Induced periosteum a complex cellular scaffold for the treatment of large bone defects. Bone 2013;57(2):484-92.
9) Niikura T, Jimbo N, Komatsu M, et al. Histological analysis of induced membranes in patients whose bone defects were treated with the Masquelet technique to identify factors affecting the vascularity of induced membranes. J Orthop Surg Res 2021;16(1):248. doi:10.1186/s13018-021-02404-7.
10) Niikura T, Oda T, Jimbo N, et al. Immunohistochemical analysis revealed the expression of bone morphogenetic proteins-4, 6, 7, and 9 in human induced membrane samples treated with the Masquelet technique. J Orthop Surg Res 2022;17(1):29. doi:10.1186/s13018-022-02922-y.
11) Cho JW, Kent WT, Oh CW, et al. Bone-craft resorption reduced by the induced membrane technique and factors affecting volumetric changes:an analysis of 120 serial computed tomographic scans in 40 patients. J Bone Joint Surg Am 2020;102(14):1269-78.
12) 新倉隆宏,大江啓介.CLAPの臨床—慢性骨髄炎,感染性偽関節に対するCLAPの応用Orthopaedics 2022;35(8):61-71.
13) 圓尾明弘.骨軟部感染症に対するCLAPの治療.臨整外2021;56(12):1455-60.
14) Maruo A, Oda T, Mineo R, et al. Continuous local antibiotic perfusion:A treatment strategy that allows implant retention in fracture-related infections. J Orthop Surg (Hong Kong) 2022;30(2):10225536221111902. doi:10.1177/10225536221111902.
15) Maruo A, Oda T, Miya H, et al. Intra-medullary antibiotics perfusion (iMAP) for the control of fracture-related infection early after osteosynthesis. J Orthop Surg (Hong Kong) 2021;29(3):23094990211051492. doi:10.1177/23094990211051492.